Organigram Holdings Inc. (TSE:OGI – Free Report) – Atb Cap Markets issued their Q1 2025 earnings per share (EPS) estimates for Organigram in a research report issued to clients and investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings per share of ($0.03) for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.
Other analysts also recently issued reports about the stock. Canaccord Genuity Group lowered their price target on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a report on Monday, December 9th. ATB Capital decreased their price objective on shares of Organigram from C$5.25 to C$3.50 in a research report on Tuesday, December 17th.
Organigram Stock Performance
Organigram stock opened at C$2.25 on Monday. The firm has a market cap of C$244.28 million, a PE ratio of -0.90, a P/E/G ratio of 0.42 and a beta of 1.13. Organigram has a 12 month low of C$1.67 and a 12 month high of C$3.95. The stock’s 50 day simple moving average is C$2.25 and its two-hundred day simple moving average is C$2.30. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13.
Insider Activity at Organigram
In related news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is owned by corporate insiders.
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Further Reading
- Five stocks we like better than Organigram
- Most Volatile Stocks, What Investors Need to Know
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Election Stocks: How Elections Affect the Stock Market
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Investing In Preferred Stock vs. Common Stock
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.